Virus-like Vesicles Expressing Multiple Antigens for Immunotherapy of Chronic Hepatitis B

Infections with hepatitis B virus (HBV) can initiate chronic hepatitis and liver injury, causing more than 600,000 deaths each year worldwide. Current treatments for chronic hepatitis B are inadequate and leave an unmet need for immunotherapeutic approaches. We designed virus-like vesicles (VLV) as...

Descripción completa

Detalles Bibliográficos
Autores principales: Yarovinsky, Timur O., Mason, Stephen W., Menon, Manisha, Krady, Marie M., Haslip, Maria, Madina, Bhaskara R., Ma, Xianyong, Moshkani, Safiehkhatoon, Chiale, Carolina, Pal, Anasuya Chattopadhyay, Almassian, Bijan, Rose, John K., Robek, Michael D., Nakaar, Valerian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889364/
https://www.ncbi.nlm.nih.gov/pubmed/31704650
http://dx.doi.org/10.1016/j.isci.2019.10.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889364/
https://www.ncbi.nlm.nih.gov/pubmed/31704650
http://dx.doi.org/10.1016/j.isci.2019.10.040

Ejemplares similares